Skip to main content

Table 4 Abnormalities other than RGA and MRC (n =  ≥ 20)

From: Cytogenetic profile of 1791 adult acute myeloid leukemia in India

Abnormality

Patient characteristics, n (%)

Age distribution, years, n (%)

Karyotype complexity, n (%)

Assoc with RGA

 

Total

M

F

Age

p

18–20

21–39

40–59

 ≥ 60

Single

Two

 ≥ 3

Double

 ≥ 3

Minus 5

55 (3.1)

37 (67.2)

18 (32.8)

54 (21–78)

Ref*

0

12 (21.8)

25 (45.5)

18 (32.7)

0

0

55 (100)

0

2 (5.5)

Plus 4

54 (3)

35 (64.8)

19 (35.2)

38 (18–73)

0.001

5 (9.3)

23 (42.6)

18 (33.3)

8 (14.8)

10 (18.5)

14 (25.9)

30 (55.6)

4 (7.4)

4 (7.4)

Plus 6

33 (1.8)

22 (66.7)

11 (33.3)

43 (18–65)

0.009

2 (6.1)

13 (39.4)

14 (42.4)

4 (12.1)

2 (6.1)

1 (3)

30 (90.9)

0 (0)

2 (6.1)

del 6q

20 (1.1)

15 (75)

5 (25)

40.5 (18–78)

0.02

1 (5)

9 (45)

7 (35)

3 (15)

0

2 (10)

18 (90)

1 (5)

1 (5)

Plus 9

28 (1.6)

17 (60.7)

11 (39.3)

39 (18–73)

0.01

2 (7.1)

13 (46.4)

8 (28.6)

5 (17.9)

4 (14.3)

3 (10.7)

21 (75)

0 (0)

1 (3.6)

Minus 9

26 (1.5)

18 (69.2)

8 (30.8)

36 (21–78)

0.07

0 (0)

14 (53.8)

6 (23.1)

6 (23.1)

0 (0)

2 (7.7)

24 (92.3)

0 (0)

2 (7.7)

del 9q

60 (3.4)

36 (60)

24 (40)

37 (18–78)

 < 0.001

4 (6.7)

28 (46.7)

20 (33.3)

8 (13.3)

14 (23.3)

12 (20)

34 (56.7)

9 (15)

15 (25)

Plus 10

26 (1.5)

17 (65.4)

9 (34.6)

45.5 (20–78)

0.06

1 (3.8)

10 (38.5)

8 (30.8)

7 (26.9)

1 (3.8)

2 (7.7)

23 (88.5)

0 (0)

2 (7.7)

Minus 10

20 (1.1)

13 (65)

7 (35)

46 (21–75)

0.05

0 (0)

7 (35)

10 (50)

3 (15)

0 (0)

1 (5)

19 (95)

0 (0)

2 (10)

Plus 11

36 (2)

23 (63.9)

13 (36.1)

53 (19–78)

0.21

2 (5.6)

9 (25)

17 (47.2)

8 (22.2)

9 (25)

6 (16.7)

21 (58.3)

1 (2.8)

1 (2.8)

Minus 11

22 (1.2)

12 (54.5)

10 (45.5)

50.5 (20–78)

0.24

1 (4.5)

7 (31.8)

7 (31.8)

7 (31.8)

0 (0)

0 (0)

22 (100)

0 (0)

2 (9.1)

Minus 12

34 (1.9)

24 (70.6)

10 (29.4)

53 (21–77)

0.21

0 (0)

9 (26.5)

18 (52.9)

7 (20.6)

0 (0)

0 (0)

34 (100)

0 (0)

3 (8.8)

Plus 13

41 (2.3)

28 (68.3)

13 (31.7)

53 (18–75)

0.14

2 (4.9)

11 (26.8)

18 (43.9)

10 (24.4)

5 (12.2)

4 (9.8)

32 (78)

0 (0)

4 (9.8)

Plus 14

27 (1.5)

18 (66.7)

9 (33.3)

43 (18–73)

0.05

1 (3.7)

10 (37)

11 (40.7)

5 (18.5)

0 (0)

2 (7.4)

25 (92.6)

1 (3.7)

1 (3.7)

Minus 14

20 (1.1)

16 (80)

4 (20)

39 (24–59)

0.09

0 (0)

5 (25)

12 (60)

3 (15)

0 (0)

0 (0)

20 (100)

0 (0)

3 (15)

Minus 16

38 (2.1)

25 (65.8)

13 (34.2)

53 (20–82)

0.44

1 (2.6)

14 (36.8)

9 (23.7)

14 (36.8)

0 (0)

0 (0)

38 (100)

0 (0)

1 (2.6)

Minus 18

48 (2.7)

34 (70.8)

14 (29.2)

49.5 (18–78)

0.09

1 (2.1)

15 (31.3)

18 (37.5)

14 (29.2)

0 (0)

3 (6.3)

45 (93.8)

1 (2.1)

3 (6.3)

Plus 19

45 (2.5)

34 (75.6)

11 (24.4)

40 (18–73)

0.004

2 (4.4)

20 (44.4)

14 (31.1)

9 (20)

5 (11.1)

2 (4.4)

38 (84.4)

1 (2.2)

8 (17.8)

Minus 20

24 (1.3)

18 (75)

6 (25)

53 (19–78)

0.77

1 (4.2)

7 (29.2)

9 (37.5)

7 (29.2)

0 (0)

2 (8.3)

22 (91.7)

0 (0)

2 (8.3)

Plus 21

83 (4.6)

46 (55.4)

37 (44.6)

40 (18–73)

 < 0.001

4 (4.8)

37 (44.6)

30 (36.1)

12 (14.5)

16 (19.3)

10 (12)

57 (68.7)

1 (1.2)

14 (16.9)

Minus 21

24 (1.3)

16 (66.7)

8 (33.3)

48.5 (21–78)

0.1

0 (0)

11 (45.8)

7 (29.2)

7 (29.2)

0 (0)

0 (0)

24 (100)

0 (0)

0 (0)

Plus 22

43 (2.4)

30 (69.8)

13 (30.2)

43 (18–78)

0.003

2 (4.7)

18 (41.9)

16 (37.2)

7 (16.3)

1 (2.3)

7 (16.3)

35 (81.4)

3 (7)

6 (14)

Minus 22

22 (1.2)

14 (63.6)

8 (36.4)

53 (20–78)

0.28

1 (4.5)

6 (27.3)

9 (40.9)

6 (27.3)

0 (0)

0 (0)

22 (100)

0 (0)

2 (9.1)

Minus X

37 (2.1)

7 (18.9)

30 (81.1)

37 (18–70)

 < 0.001

4 (10.8)

18 (48.6)

12 (32.4)

3 (8.1)

0 (0)

16 (43.2)

21 (56.8)

14 (37.8)

9 (24.3)

Minus Y

81 (4.5)

0 (0)

81 (100)

36 (18–74)

 < 0.001

7 (8.6)

39 (48.1)

25 (30.9)

10 (12.3)

10 (12.3)

47 (58)

24 (29.6)

47 (58)

10 (12.3)

  1. *Reference for p value